Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Covetrus North America Now Offers Unique In-Clinic Regenerative Medicine Devices by Enso Discoveries, LLC Including Rebound PRP™ and Rebound PRF®

Enso Discoveries, an emerging biotech company, and Covetrus, a global animal-health technology and services company, are partnering to bring Rebound PRP and Rebound PRF to the veterinary industry -- revolutionary, affordable, easy-to-use regenerative medical devices for use on horses, cattle, dogs, and cats.


News provided by

Enso Discoveries, LLC

Feb 26, 2020, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Rebound PRP helped Katie May with her canine hip dysplasia.
Rebound PRP helped Katie May with her canine hip dysplasia.

MANHATTAN, Kan., Feb. 26, 2020 /PRNewswire-PRWeb/ -- Enso Discoveries, LLC proudly announces that its patent-pending Rebound PRP™ and Rebound PRF® devices are now available to veterinary practices through Covetrus. Enso Discoveries has designed and university-validated a new generation of regenerative medical devices, that will provide the most affordable, easiest to use, multi-species validated, platelet-rich plasma and platelet-rich fibrin systems that have ever been available to the veterinary market.

"The partnership between Enso Discoveries and Covetrus is a very exciting and natural fit. Both companies strive to offer high quality, innovative services/products that will allow the veterinarian to keep their hard-earned revenues in their respective clinics," said Patrick Farley, CEO of Enso Discoveries, LLC.

“Virtually every veterinarian we speak to has patients that are caught between the need for long term daily pain meds and the inability to have surgery for various reasons. Offering Rebound PRP is a new option for these clinics." - Corey Orava, DVM, Chief Scientific Officer, Enso Discoveries, LLC

Post this

With the goal of improving quality of life while generating service-based revenues, Enso Discoveries has taken the lead in accessible, unique, affordable and validated veterinary regenerative medicine products with Rebound PRP and Rebound PRF. As the largest distributor in the veterinary world, Covetrus can now offer regenerative medicine that does not require veterinarians or clinics to invest in expensive upfront equipment. This removes the long-term financial risk for progressive practices interested in offering regenerative medicine to their patients.

Enso Discoveries recently shared the success of 20-plus dogs treated with Rebound PRP by Brian Davis, MS, DVM at Green Valley Animal Hospital in Wamego, Kansas. Each dog received one intra-articular injection and was then followed for up to 20 weeks post-injection. There were no serious adverse events reported and all but one patient improved significantly.

"Virtually every veterinarian we speak to has patients that are caught between the need for long term daily pain meds and the inability to have surgery for various reasons. Offering Rebound PRP is a new option for these clinics. The high degree of client-acceptance for this service, even in rural areas as demonstrated by Dr. Davis, fulfills one of our core missions: making regenerative medicine more accessible," said Corey Orava, DVM, Chief Scientific Officer of Enso Discoveries.

Conditions generating the most interest for PRP include:
-Arthritis and joint issues (OA)
-Tendon, ligament, and muscle injuries
-Theriogenology

The first of its kind in veterinary medicine, Rebound PRF has been used successfully for complicated dental conditions, as well as severe and non-healing wounds. Clinics can offer the Rebound PRF device as a wholesale solution or part of another treatment for advanced wound healing in emergency cases, trauma cases, dental surgeries, unusually difficult chronic cases and more.

Uses to consider for Rebound PRF:
-Acute, chronic and non-healing wounds
-Dentistry: multiple tooth extractions, feline gingivitis, carnassial extractions
-Bone repair
-Graft stabilization

Animal owners have already experienced the success of these products with their beloved family pets, with numerous vets reporting they were able to avoid amputation by healing wounds that were refractory to other treatments.

Both Rebound PRP and Rebound PRF were designed by veterinarians for veterinarians, were validated at Kansas State University Veterinary Diagnostic Laboratory in multiple species, and are adjustable therapies to produce a customized amount of PRP or PRF that a patient might need for optimum healing.

###

Enso Discoveries, LLC is a biotech company focused on enhancing the lives of animals through the development of relevant, cost-effective, novel technology that allows our valued customer, the veterinarian, to keep their hard-earned business in house. We support our products and services with scientific proof, national distribution partners, and a worldwide network of industry experienced contacts. Ask your veterinarian or veterinary products distributor about Enso Discoveries, LLC products such as Rebound PRP™ and Rebound PRF® or learn more at http://www.ensodiscoveries.com.

SOURCE Enso Discoveries, LLC

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.